If for whatever reason, you decide you definitely want a RP, I would then
not send your biopsy slides for genomic testing, but instead, wait and having the Decipher test done on your RP tissue.
Decipher Biopsy results, for example, agree with post-RP tissue testing for the same patient (only) about
70% of the time (as is stated in small print on the Decipher Biopsy report itself). The reason is not test inaccuracy, but is the same that explains upgrading of Gleason scores from biopsy to RP: the biopsy samples a tiny amount of prostate tissue, and may not have hit the most serious of your lesions. One chap on another Forum actually got back a low-risk Decipher score on his biopsied tissue and high-risk on the RP tissue!
AFAIK, this possible change in risk goes only in the direction of upgrading (low-> intermediate -> high), in other words, I think it would very rare to test high-risk for mets on your biopsy tissue and low risk afterards on RP tissue. This differs from Gleason score, which can be downgraded from biopsy to RP because a biopsy grade is by convention that of the
highest-grade lesion found. When the whole prostate is sampled after a RP, the actual percentages of the different Gleason patterns can be accurately established. Thus the highest-grade lesion found at biopsy is not representative of lesions throughout the prostate about
two-thirds of the time, resulting in up- or down-grading.
Your biopsy Gleason score is only an estimate of your "actual" score. For men who choose RT, it is their final one, however.
DJin
Post Edited (DjinTonic) : 8/10/2020 1:50:05 PM (GMT-6)